Andra AP fonden Has $19.62 Million Holdings in The Clorox Company $CLX

Andra AP fonden increased its holdings in shares of The Clorox Company (NYSE:CLX) by 175.0% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 194,600 shares of the company’s stock after acquiring an additional 123,843 shares during the quarter. Andra AP fonden’s holdings in Clorox were worth $19,622,000 at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in CLX. Norges Bank acquired a new stake in Clorox during the 4th quarter worth $135,735,000. Van ECK Associates Corp raised its stake in shares of Clorox by 93.9% in the 3rd quarter. Van ECK Associates Corp now owns 2,709,972 shares of the company’s stock valued at $334,139,000 after purchasing an additional 1,312,471 shares during the period. Invesco Ltd. raised its stake in shares of Clorox by 23.1% in the 3rd quarter. Invesco Ltd. now owns 3,995,590 shares of the company’s stock valued at $492,656,000 after purchasing an additional 750,415 shares during the period. Northwestern Mutual Wealth Management Co. raised its stake in shares of Clorox by 6,907.9% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 749,703 shares of the company’s stock valued at $75,593,000 after purchasing an additional 739,005 shares during the period. Finally, Worldquant Millennium Advisors LLC acquired a new stake in shares of Clorox in the 2nd quarter valued at about $71,856,000. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Trading Down 0.8%

Clorox stock opened at $98.48 on Friday. The Clorox Company has a 52 week low of $84.70 and a 52 week high of $132.03. The company has a debt-to-equity ratio of 27.03, a quick ratio of 0.65 and a current ratio of 0.84. The stock has a market capitalization of $11.91 billion, a P/E ratio of 15.99, a PEG ratio of 0.52 and a beta of 0.56. The stock has a 50-day simple moving average of $96.58 and a 200 day simple moving average of $105.26.

Clorox (NYSE:CLX) last posted its quarterly earnings results on Thursday, April 30th. The company reported $1.64 EPS for the quarter, topping analysts’ consensus estimates of $1.55 by $0.09. The business had revenue of $1.67 billion during the quarter, compared to analysts’ expectations of $1.67 billion. Clorox had a return on equity of 443.64% and a net margin of 11.18%.Clorox’s quarterly revenue was up .1% on a year-over-year basis. During the same quarter last year, the company posted $1.45 earnings per share. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. Analysts expect that The Clorox Company will post 5.61 earnings per share for the current year.

Insider Transactions at Clorox

In related news, Director Pierre R. Breber acquired 5,000 shares of the business’s stock in a transaction on Tuesday, May 5th. The stock was purchased at an average cost of $85.82 per share, for a total transaction of $429,100.00. Following the completion of the transaction, the director directly owned 18,000 shares of the company’s stock, valued at approximately $1,544,760. The trade was a 38.46% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 0.63% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

Several research firms have issued reports on CLX. Citigroup dropped their price target on Clorox from $110.00 to $97.00 and set a “neutral” rating on the stock in a research note on Friday, May 1st. TD Cowen lifted their price target on Clorox from $98.00 to $111.00 and gave the company a “hold” rating in a research note on Tuesday, March 31st. Evercore restated an “underperform” rating and issued a $110.00 price objective on shares of Clorox in a report on Friday, May 1st. Morgan Stanley decreased their price objective on Clorox from $110.00 to $97.00 and set an “equal weight” rating for the company in a report on Friday, May 1st. Finally, UBS Group decreased their price objective on Clorox from $110.00 to $96.00 and set a “neutral” rating for the company in a report on Friday, May 1st. One investment analyst has rated the stock with a Buy rating, eleven have given a Hold rating and five have assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Reduce” and a consensus target price of $103.40.

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.